- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sana Biotechnology Inc (SANA)
Sana Biotechnology Inc stock price live, this page displays NASDAQ SANA stock exchange data. View the SANA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sana Biotechnology Inc real time stock price chart below.
What Is the Sana Biotechnology Inc Stock Price Today?
The Sana Biotechnology Inc stock price today is 3.54.
What Is the Stock Symbol for Sana Biotechnology Inc?
The stock symbol for Sana Biotechnology Inc is "SANA."
What Stock Exchange Does Sana Biotechnology Inc Trade On?
Sana Biotechnology Inc is listed and trades on the NASDAQ stock exchange.
Is Sana Biotechnology Inc a Good Stock to Buy?
Determining whether Sana Biotechnology Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SANA quote. (ISIN: US7995661045)
What Is the Sana Biotechnology Inc Stock Price Today?
The Sana Biotechnology Inc stock price today is 3.54.
What Is the Stock Symbol for Sana Biotechnology Inc?
The stock symbol for Sana Biotechnology Inc is "SANA."
What Stock Exchange Does Sana Biotechnology Inc Trade On?
Sana Biotechnology Inc is listed and trades on the NASDAQ stock exchange.
Is Sana Biotechnology Inc a Good Stock to Buy?
Determining whether Sana Biotechnology Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SANA quote. (ISIN: US7995661045)
3.54
-0.13(-3.58%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.51
3.64
52 wk Range
2.61
6.55
SANA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.513.64
52 wk Range
2.616.55
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SANA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
8.57
Upside
+142.13%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price movements are quite volatile
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 8.57
(+142.13% Upside)
Sana Biotechnology Inc SWOT Analysis
Innovative Therapy | Sana Biotechnology's Hypoimmune platform aims to revolutionize cell therapy, potentially enabling allogeneic transplantation without immunosuppression |
Promising Pipeline | Explore Sana's diverse portfolio, including UP421 for type 1 diabetes and SC291 for autoimmune diseases, with key milestones expected in 2025-2026 |
Market Potential | Analysts estimate SC451 could target 111,000 US patients by 2030, with risk-adjusted peak sales of $1.9 billion and unadjusted potential of $9.6 billion |
Investment Outlook | With analyst targets ranging from $5 to $12, Sana presents a high-risk, high-reward opportunity in the competitive biotechnology landscape |
Earnings
Latest Release
Aug 10, 2026
EPS / Forecast
-0.13 / -0.15
Revenue / Forecast
-- / --
Compare SANA to Peers and Sector
Metrics to compare | SANA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSANAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.2x | 4.8x | −0.4x | |
PEG Ratio | −0.18 | −0.23 | 0.00 | |
Price/Book | 7.1x | 4.2x | 2.6x | |
Price / LTM Sales | - | 4.1x | 3.1x | |
Upside (Analyst Target) | 90.7% | 212.5% | 48.4% | |
Fair Value Upside | Unlock | 23.6% | 6.5% | Unlock |
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company’s product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modified, stem cell derived pancreatic islet cell therapy, which is in preclinical trial for the treatment of type 1 diabetes; SG293 and SG299, a CD8-targeted fusosome for the treatment of B cell hematologic malignancies and B cell mediated autoimmune diseases. The company has an option and license agreement with Beam Therapeutics Inc. for use of Beam’s proprietary CRISPR Cas12b nuclease editing technology to research, develop, and commercialize engineered cell therapy products; and a license agreement with Harvard College to access certain intellectual property for the development of hypoimmune-modified cells. The company has a strategic collaboration with Mayo Clinic for the development of SC451, a hypoimmune-modified pancreatic islet cell therapy for type 1 diabetes. The company was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. Sana Biotechnology, Inc. was incorporated in 2018 and is headquartered in Seattle, Washington.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Sana Biotechnology (SANA) Stock Price Today?
The Sana Biotechnology stock price today is 3.54 USD.
What Stock Exchange Does Sana Biotechnology Trade On?
Sana Biotechnology is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Sana Biotechnology?
The stock symbol for Sana Biotechnology is "SANA."
What Is the Sana Biotechnology Market Cap?
As of today, Sana Biotechnology market cap is 1.06B USD.
What Is Sana Biotechnology's Earnings Per Share (TTM)?
The Sana Biotechnology EPS (TTM) is -0.76.
When Is the Next Sana Biotechnology Earnings Date?
Sana Biotechnology will release its next earnings report on Nov 05, 2026.
From a Technical Analysis Perspective, Is SANA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Sana Biotechnology Stock Split?
Sana Biotechnology has split 0 times.
How Many Employees Does Sana Biotechnology Have?
Sana Biotechnology has 142 employees.
What is the current trading status of Sana Biotechnology (SANA)?
As of Aug 14, 2026, Sana Biotechnology (SANA) is trading at a price of 3.54 USD, with a previous close of 3.67 USD. The stock has fluctuated within a day range of 3.51 USD to 3.64 USD, while its 52-week range spans from 2.61 USD to 6.55 USD.
What Is Sana Biotechnology (SANA) Price Target According to Analysts?
The average 12-month price target for Sana Biotechnology is 8.57 USD, with a high estimate of 12 USD and a low estimate of 7 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +142.13% Upside potential.
What Is the SANA Premarket Price?
SANA's last pre-market stock price is 3.63 USD. The pre-market share volume is 107,830.00, and the stock has decreased by -0.04, or -1.09%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.